VIVE - Viveve Medical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 519.53M
Enterprise Value 331.58M
Trailing P/E N/A
Forward P/E 1-0.76
PEG Ratio (5 yr expected) 1-0.03
Price/Sales (ttm)1.10
Price/Book (mrq)N/A
Enterprise Value/Revenue 31.77
Enterprise Value/EBITDA 6-0.78

Trading Information

Stock Price History

Beta (3Y Monthly) 0.01
52-Week Change 3-82.99%
S&P500 52-Week Change 36.69%
52 Week High 33.7100
52 Week Low 30.3500
50-Day Moving Average 30.4496
200-Day Moving Average 30.7662

Share Statistics

Avg Vol (3 month) 31.12M
Avg Vol (10 day) 32.52M
Shares Outstanding 546.49M
Float 30.76M
% Held by Insiders 12.88%
% Held by Institutions 168.49%
Shares Short (Jun 28, 2019) 46.38M
Short Ratio (Jun 28, 2019) 45.41
Short % of Float (Jun 28, 2019) 416.44%
Short % of Shares Outstanding (Jun 28, 2019) 413.72%
Shares Short (prior month May 31, 2019) 44.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -265.51%
Operating Margin (ttm)-233.65%

Management Effectiveness

Return on Assets (ttm)-56.92%
Return on Equity (ttm)-651.20%

Income Statement

Revenue (ttm)17.83M
Revenue Per Share (ttm)0.49
Quarterly Revenue Growth (yoy)-18.60%
Gross Profit (ttm)7.32M
EBITDA -40.71M
Net Income Avi to Common (ttm)-47.34M
Diluted EPS (ttm)-1.3080
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.82M
Total Cash Per Share (mrq)0.38
Total Debt (mrq)31.5M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.95
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-39.46M
Levered Free Cash Flow (ttm)-25.17M